Maythinee Chantadisai (M Chantadisai)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Prostate Cancer

Positron Emission Tomography

Ejection Fraction

Top Venues

Journal of nuclear medicine : official publication, Society of Nuclear Medicine

European journal of nuclear medicine and molecular imaging

Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Thai Red Cross Society

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Faculty of Medicine, Chulalongkorn University, King Chulalongkorn Memorial Hospital, Thai Red Cross Society Jun 15 2013

Thailand

Dr. :: Division of Nuclear Medicine, Radiology

Publications

Lukas Lunger, Maythinee Chantadisai, Amir Karimzadeh, Isabel Rauscher, Calogero D'Alessandria, Benedikt Feuerecker, Thomas Langbein, Robert Tauber, Stefan Schiele, Wolfgang Andreas Weber, Matthias Eiber
The prognostic role of 68 Ga-PSMA11 PET-based response in prostate cancer patients undergoing taxane-based chemotherapy. Journal of nuclear medicine : official publication, Society of Nuclear Medicine (2022)
Richard P Baum, Christiane Schuchardt, Aviral Singh, Maythinee Chantadisai, Franz C Robiller, Jingjing Zhang, Dirk Mueller, Aleksandr Eismant, Frankis Almaguel, Dirk Zboralski, Frank Osterkamp, Aileen Hoehne, Ulrich Reineke, Christiane Smerling, Harshad R Kulkarni
Feasibility, Biodistribution and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy (PTRT) of Diverse Adenocarcinomas using 177Lu-FAP-2286: First-in-Human Results. Journal of nuclear medicine : official publication, Society of Nuclear Medicine (2021)
Maythinee Chantadisai, H R Kulkarni, R P Baum
Therapy-related myeloid neoplasm after peptide receptor radionuclide therapy (PRRT) in 1631 patients from our 20 years of experiences: prognostic parameters and overall survival. European journal of nuclear medicine and molecular imaging 48 (5) (2020)